1. Home
  2. NTGR vs MNMD Comparison

NTGR vs MNMD Comparison

Compare NTGR & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTGR
  • MNMD
  • Stock Information
  • Founded
  • NTGR 1996
  • MNMD 2019
  • Country
  • NTGR United States
  • MNMD United States
  • Employees
  • NTGR N/A
  • MNMD N/A
  • Industry
  • NTGR Telecommunications Equipment
  • MNMD Pharmaceuticals and Biotechnology
  • Sector
  • NTGR Utilities
  • MNMD Health Care
  • Exchange
  • NTGR Nasdaq
  • MNMD Nasdaq
  • Market Cap
  • NTGR 776.6M
  • MNMD 811.9M
  • IPO Year
  • NTGR N/A
  • MNMD N/A
  • Fundamental
  • Price
  • NTGR $32.11
  • MNMD $11.91
  • Analyst Decision
  • NTGR Strong Buy
  • MNMD Strong Buy
  • Analyst Count
  • NTGR 3
  • MNMD 6
  • Target Price
  • NTGR $34.67
  • MNMD $26.50
  • AVG Volume (30 Days)
  • NTGR 396.6K
  • MNMD 1.7M
  • Earning Date
  • NTGR 10-29-2025
  • MNMD 11-06-2025
  • Dividend Yield
  • NTGR N/A
  • MNMD N/A
  • EPS Growth
  • NTGR N/A
  • MNMD N/A
  • EPS
  • NTGR 2.16
  • MNMD N/A
  • Revenue
  • NTGR $697,865,000.00
  • MNMD N/A
  • Revenue This Year
  • NTGR $4.49
  • MNMD N/A
  • Revenue Next Year
  • NTGR $3.83
  • MNMD N/A
  • P/E Ratio
  • NTGR $15.06
  • MNMD N/A
  • Revenue Growth
  • NTGR 0.41
  • MNMD N/A
  • 52 Week Low
  • NTGR $18.75
  • MNMD $4.70
  • 52 Week High
  • NTGR $34.49
  • MNMD $12.76
  • Technical
  • Relative Strength Index (RSI)
  • NTGR 65.41
  • MNMD 64.95
  • Support Level
  • NTGR $28.14
  • MNMD $8.77
  • Resistance Level
  • NTGR $34.49
  • MNMD $12.76
  • Average True Range (ATR)
  • NTGR 1.13
  • MNMD 0.81
  • MACD
  • NTGR 0.23
  • MNMD 0.21
  • Stochastic Oscillator
  • NTGR 60.00
  • MNMD 80.44

About NTGR NETGEAR Inc.

Netgear Inc provider of networking technologies for businesses, homes, and service providers. It delivers a wide range of intelligent solutions designed to unleash the full potential of connectivity. The group has two segments: NETGEAR for Business and Connected Home which offers reliable, easy-to-use, high-performance networking solutions, including switches, routers, access points, software, and AV over IP technologies, tailored to meet the diverse needs of organizations of all sizes. The Connected Home segment offers connectivity, powerful performance, and enhanced security features right out of the box, designed to help keep families safe online, and Others. It conduct business across three geographic territories: Americas; Europe, Middle East and Africa; and Asia Pacific.

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

Share on Social Networks: